We are live on ! Find out more
AYTU icon

AYTU BioPharma

8 hedge funds and large institutions have $8.23M invested in AYTU BioPharma in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,080% more capital inflows, than outflows

Capital inflows: $2.78M | Capital outflows: $236K

8.27% more ownership

Funds ownership: 32.53% → 40.81% (+8.3%)

33% less funds holding

Funds holding: 12 → 8 (-4)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
8
Holders Change
-4
Holders Change %
-33.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AYTU Hedge Fund Activity: Q4 2019 in Review

8 of the 5,095 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q4 2019, worth a combined $8.23M — up 18% from $6.96M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of AYTU and 2 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Armistice Capital, adding an estimated $2.72M. The largest seller was Wexford Capital, exiting entirely with an estimated $123K sold.

  • 8 institutional investors held AYTU BioPharma (AYTU) as of Q4 2019, down from 12 in Q3 2019.
  • Funds reported $8.23M of AYTU BioPharma stock for Q4 2019, up 18% quarter-over-quarter.
  • 2 funds opened new AYTU BioPharma positions in Q4 2019 and 6 closed out, a net change of -4 holders.
  • The largest AYTU BioPharma buyer in Q4 2019 was Armistice Capital, an estimated $2.72M added.
  • The largest AYTU BioPharma seller in Q4 2019 was Wexford Capital, an estimated $123K sold.

Based on aggregated 13F filings for Q4 2019.